Hung Phi Do1, Venkat Ramanan2, Graham A Wright2,3, Nilesh R Ghugre2,3, and Krishna S Nayak4
1Department of Physics and Astronomy, University of Southern California, Los Angeles, CA, United States, 2Physical Sciences Platform, Sunnybrook Research Institute, Toronto, ON, Canada, 3Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada, 4Ming Hsieh Department of Electrical Engineering, University of Southern California, Los Angeles, CA, United States
Synopsis
Myocardial vasodilatory response is an important indicator of
microvascular function and viability. Arterial spin labeled (ASL) CMR is a
non-contrast method that can quantify myocardial blood flow making it
attractive to study vasodilatory response. In this work, we demonstrate the
feasibility of ASL in the assessment of regional vasodilatory response in a
porcine model of acute myocardial infarction (AMI) using a pharmacological
stress agent. Quantitative monitoring of microvascular function in the
infarcted, salvageable and remote myocardial territories may potentially help identify
patients who are prone to adverse long-term remodeling post-AMI.Background
Following acute myocardial infarction (AMI),
microvascular integrity and function may be compromised as a result of
microvascular obstruction (MVO) and vasodilatory dysfunction.
1-3 It has been
observed that both infarct and remote myocardial territories may exhibit
impaired myocardial blood flow (MBF) patterns associated with abnormal
vasodilatory response.
4 Arterial spin labeled CMR (ASL-CMR) is a non-contrast
MR based technique that can quantify myocardial perfusion.
5-7 This study
aims to investigate the feasibility of ASL-CMR in the quantitative assessment
of myocardial blood flow and vasodilator response in the infarct and remote
myocardial territories following AMI in a porcine model of ischemic injury.
Methods
Our Institute’s
Animal Care Committee approved the protocol. The porcine AMI model involved a 90
min left anterior descending (LAD) artery occlusion followed by reperfusion.
Animals underwent a CMR examination on a 3T scanner (MR750, GE Healthcare) at
baseline (N=7, healthy state) and post-AMI (N=3, week 1 and week 4). The
imaging protocol involved ASL-CMR, first-pass perfusion, and late gadolinium
enhancement (LGE) imaging. ASL-CMR was performed using our investigational
pulse sequence
7 that uses flow-sensitive alternating inversion recovery
(FAIR) labeling and steady state free precession (SSFP) image acquisition (parameters:
TE/TR=1.5/3.2ms, FA = 50
o, slice thickness = 10mm, FOV=18-24cm,
matrix size of 96x96, parallel imaging factor of 2). ASL-CMR was performed on one (3 animals) and two (7 animals) mid-ventricular slices at the infarct location resulting in 12 slices at baseline and 5 slices at post-AMI. The ASL scan was repeated following an intravenous injection
of Dipyridamole (0.56 mg/kg over 4 min) to assess vasodilatory function. Finally,
first-pass perfusion and (LGE) imaging were performed using product sequences following
injection of gadolinium-DTPA (Magnevist, 0.2 mmol/kg) to identify perfusion
abnormalities and the infarcted tissue; LGE was initiated at 8 min
post-injection. ASL-CMR was analyzed in a manner previously described
7 to obtain
global and per-segment myocardial blood flow (MBF), physiological noise (PN),
and myocardial perfusion reserve (MPR=MBF
stress/MBF
rest);
values were reported as mean±SD. Segments with temporal signal-to-noise ratio
(tSNR=MBF/PN) < 2 were excluded from analysis.
Results
Figure 1 shows
myocardial ASL maps at rest and during stress in comparison with first-pass CMR
and LGE. Area with low perfusion at rest and during stress (arrows) are in good
agreement with perfusion deficit in first-pass perfusion and MVO in LGE.
Figure 2 shows global MBF
and MPR at baseline and post-AMI. Global stress MBF values were significantly
elevated compared to rest at both baseline (resting MBF = 0.99 ± 0.28 and
stress MBF = 1.52 ± 0.29 ml/g/min, p< 0.001) and post-AMI (rest MBF =
0.62 ± 0.18 and stress MBF = 1.19 ± 0.44, p < 0.001). When
compared between baseline and post-AMI, global rest MBF (baseline MBF = 0.99 ±
0.28 and post-AMI MBF = 0.62 ± 0.18, p = 0.02) was significantly different, stress MBF (baseline MBF = 1.30 ± 0.33 and post-AMI MBF = 1.22 ±
0.40, p = 0.08) and MPR (baseline MPR = 1.62 ± 0.46 and post-AMI
MPR = 1.96 ± 0.72, p = 0.26) were not significantly different.
Differences
in regional flow and stress patterns were apparent. Figure 3 shows regional MBF from remote and infarcted segments at
rest and stress. Resting MBF in the
infarcted territory was significantly depressed when compared to baseline
values (post-AMI MBF = -0.06 ± 0.24 and baseline MBF = 0.85 ± 0.28 ml/g/min
with p<0.001) indicative of severe microvascular damage. Under stress
conditions, the infarcted region showed a marginal vasodilatory response (resting
MBF = -0.06 ± 0.24 and stress MBF = 0.56 ± 0.08, p <0.001)
potentially indicative of vascular activity in the salvageable myocardium; this
response was however less than that at baseline (baseline stress MBF = 1.45 ±
0.31 and post-AMI stress MBF = 0.56 ± 0.08, p <0.001).
Interestingly, resting
MBF in the remote myocardium post-AMI was also compromised when compared to
baseline (baseline resting MBF = 1.05 ± 0.44 and post-AMI resting MBF = 0.55 ±
0.18 ml/g/min, p=0.03) potentially indicative of vasoconstriction
(neurosympathetic or due to edema). With stress, the remote tissue post-AMI appeared
to respond very similar to baseline (baseline stress MBF = 1.62 ± 0.46 and
post-AMI stress MBF = 1.48 ± 0.67, p=0.61) possibly due to a
compensatory mechanism.
Conclusions
Our study
demonstrates the feasibility of ASL-CMR in the assessment of regional and
serial vasodilatory response following acute myocardial infarction. ASL-CMR
could potentially be a useful non-contrast imaging tool to detect and monitor microvascular
function not only in the infarcted region but also the salvageable and remote
regions, which may be early indicators of downstream adverse remodeling
processes post-injury.
Acknowledgements
The Ontario Research Fund; American Heart Association
13GRNT13850012; Wallace H. Coulter Foundation Clinical Translational Research
Award.References
1. Jaffe R et al., Circulation.
2008; 117:3152-56.
2. Ishihara M et al., Br
Heart J. 1993; 69:288-92
3. Ghugre NR et al., Magn
Reson Med. 2013 Oct;70(4):1095.
4. Uren NG et al., N
Engl J Med. 1994; 331(4):222-27
5. Zun Z et al., Magn
Reson Med. 2009; 62(4):975-83.
6. Zun Z et al., iJACC.
2011; 4(12):1253-61.
7. Do HP et al., J Cardiovasc Magn Reson.
2014; 16:15.